Mr. Hoh is a Managing Director in Investment Banking at T.R. Winston & Company, LLC and has over 20 years of health care experience in investment banking, asset management and venture capital. Mr. Hoh is also the Co-Founder and Chairman of CentreLink, a platform healthcare company dedicated to rapidly advancing innovation in China. Mr. Hoh also serves as a Board Member of the Huntington Study Group, a non-profit dedicated to seeking treatments that make a difference in Huntington’s disease.  Prior to joining T.R. Winston, Mr. Hoh was the Founder and Managing Member of Goldwater Management, an investment, consulting and strategic advisory firm which specializes in global health care.  In addition, he was an advisor to 3E Bioventures, a China-based venture capital firm investing in global health care. Mr. Hoh has over sixteen years of direct investing experience managing portfolios at top institutions including Soros and SAC Capital. In addition, Mr. Hoh has over ten years of experience investing in China health care. Most recently, he has been an advisor to several public and private health care companies where he has been engaged to advise companies on corporate strategy, business development, raise capital, license products and form joint ventures.  Mr. Hoh began his Wall Street career at Donaldson, Lufkin and Jenrette as a Research Associate in Specialty Pharmaceuticals.  Prior to that, Mr. Hoh started his professional career at The Advisory Board Company, a health care focused consulting firm based in Washington, DC. He holds a BS in Biology and Philosophy from the University of Michigan and an MS in Physiology at Georgetown University.